Guerbet (FR0000032526 GBT), a global leader in medical imaging, announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol),...
Stryker, one of the world's leading medical technology companies, announced that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S....
Infixion Bioscience, a pre-clinical drug discovery company focused on developing gene-targeted therapeutics for the rare genetic disorder Neurofibromatosis Type 1 (NF1), announced the awarding...
Koji Tanabe of I Peace, Inc. and a researcher Hiroko Nobuta of the University of California, San Francisco (currently assistant professor at Rutgers University)...
Cellistic, the cell therapy development and manufacturing business of Ncardia BV, and Celyad Oncology, a clinical-stage biotechnology company focused on the discovery and development...
